Aphexda Injection, Powder, Lyophilized, For Solution
Product Images NDC 73441-062

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Aphexda (NDC 73441-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gamida Cell Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Aphexda 01)

FDA Label Image

Chemical Structure (Aphexda 02)

FDA Label Image

Chemical Structure (Aphexda 03)

FDA Label Image

Chemical Structure (Aphexda 04)

FDA Label Image

Principal Display Panel (62 mg Vial Carton)

Principal Display Panel (62 mg Vial Carton)
The text contains information about a medication called APHEXDA™®. It provides details on storage instructions, reconstitution guidelines, composition, and dosage of the product. The medication is supplied in vials containing motixafortide acetate, sodium chloride injection, hydrochloric acid, and mannitol. It is intended for subcutaneous injection and should be stored between 2°C to 8°C. It is essential to keep the product out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.